TradingAgents AISign inGet started
All stock profiles
BMEANASDAQHealthcare

BIOMEA FUSION INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$0.64

+2.68%

Alpha Vantage · 10/30/2026

Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze BMEA free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

-50.9%

3 months

-46.8%

6 months

-53.4%

1 year

-52.0%

Year to date

-48.5%

52-week range

$0.59 – $2.21

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$46.3M

P/E

-1.4

P/B

3.8

P/S

—

Revenue

$0

Net income

-$32.54M

Diluted EPS

-0.29

Gross margin

—

Net margin

—

Return on equity

-171.20%

Total debt

$877K

Cash

$35.19M

Free cash flow

-$46.64M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$0-$8.33M——-$10.03M
Mar 31, 2026$0-$12.42M——-$11.12M
Dec 31, 2025$0$4.61M——-$13.94M
Sep 30, 2025$0-$16.41M——-$11.55M
Jun 30, 2025$0-$20.74M——-$19.21M
Mar 31, 2025$0-$29.26M——-$25.67M
Dec 31, 2024$0-$29.3M——-$30.09M
Sep 30, 2024$0-$32.79M——-$25.4M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent BMEA news

All market news

No ticker-linked stories are in the current archive.